Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MTAC

MedTech Acquisition (MTAC) Stock Price, News & Analysis

MedTech Acquisition logo

About MedTech Acquisition Stock (NASDAQ:MTAC)

Advanced Chart

Key Stats

Today's Range
$8.96
$12.83
50-Day Range
$9.34
$11.34
52-Week Range
$8.43
$12.83
Volume
183,276 shs
Average Volume
9,656 shs
Market Capitalization
$83.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC.

Receive MTAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

MTAC Stock News Headlines

Shocking AI play that’s beats Nvidia by a country mile
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.
SMTI Sanara MedTech Inc.
See More Headlines

MTAC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that MedTech Acquisition investors own include Ginkgo Bioworks (DNA), BYD (BYDDY), Spire Global (SPIR), Altimeter Growth (AGC), ARK Innovation ETF (ARKK), Berkshire Hathaway (BRK.B) and Coinbase Global (COIN).

Company Calendar

Today
5/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:MTAC
Web
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$5.54 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.89 per share
Price / Cash Flow
12.80
Book Value
($2.04) per share
Price / Book
-5.56

Miscellaneous

Free Float
1,952,000
Market Cap
$83.80 million
Optionable
Not Optionable
Beta
-0.04
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:MTAC) was last updated on 5/14/2025 by MarketBeat.com Staff
From Our Partners